Company: GAUZ
Filing Date: 2025-03-11
Form Type: 20-F
Source: 0001213900-25-022437
Chunk: 202

Company: Gauzy Ltd.
Filing Date: 2025-03-11
Form: 20-F
Item: Item 19
Chunk 202
---
───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Numerator:                                                                                                                                                                
  Net loss attributable to ordinary shareholders, basic and diluted                                        $                               53,182      $            79,267  
  Denominator:                                                                                                                                                              
  Weighted-average shares used in computing net loss per share attributable to ordinary shareholders,                                  12,927,717                4,356,665  
  Net loss per share attributable to ordinary shareholders, basic and diluted                              $                                 4.11      $             18.19  

The above share
information has been adjusted to reflect the share split as discussed in note 2gg.

The following
instruments were not included in the computation of diluted earnings per share because of their anti-dilutive effect:

  Redeemable convertible preferred shares (see Note  

  Convertible loan agreements (see Note 15);  

  Warrants to purchase ordinary shares (see Note 16);  

  Share-based compensation (see Note 17).  

F-52

GAUZY LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

(U. S. dollars in thousands, except share and per
share amounts)

NOTE 20 - TRANSACTIONS AND BALANCES WITH RELATED
PARTIES:

Transactions
with related parties which are shareholders and directors of the Company:

  Transactions:  

                                                           Year ended December 31                             
                                                           2024                                 2023          
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Share-based compensation to non-executive directors      $                           682      $         56  

  Balances:  

                                                           December 31                        
                                                           2024             2023              
 ──────────────────────────────────────────────────────────────────────────────────────────────
  Short-term liabilities -                                                                    
  Other current liabilities                                $                $         -       
  Long-term liabilities -                                                                     
  CLA                                                      $                $         9,780   
  Long-term debt measured under the fair value option      $                $         21,976  

Note 21
- subsequent events:

  In January 2025, the Company paid $ 187 of the phantom warrants see Note 16d.  

  In March 2025, the 2024 Note Purchaser Warrants (see note 16g) were replaced and the Company issued an amended and restated warrant to the 2024 Note Purchasers (